Correlation Between Spectral Med and Aptose Biosciences

Can any of the company-specific risk be diversified away by investing in both Spectral Med and Aptose Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spectral Med and Aptose Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spectral Med and Aptose Biosciences, you can compare the effects of market volatilities on Spectral Med and Aptose Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spectral Med with a short position of Aptose Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spectral Med and Aptose Biosciences.

Diversification Opportunities for Spectral Med and Aptose Biosciences

0.73

Correlation Coefficient

Spectral Med  Aptose Biosciences

Poor diversification

The 3 months correlation between Spectral and Aptose is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Spectral Med and Aptose Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptose Biosciences and Spectral Med is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spectral Med are associated (or correlated) with Aptose Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptose Biosciences has no effect on the direction of Spectral Med i.e., Spectral Med and Aptose Biosciences go up and down completely randomly.

Pair Corralation between Spectral Med and Aptose Biosciences

Assuming the 90 days trading horizon Spectral Med is expected to generate 22.46 times less return on investment than Aptose Biosciences. But when comparing it to its historical volatility, Spectral Med is 31.42 times less risky than Aptose Biosciences. It trades about 0.17 of its potential returns per unit of risk. Aptose Biosciences is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  36.00  in Aptose Biosciences on December 23, 2024 and sell it today you would earn a total of  474.00  from holding Aptose Biosciences or generate 1316.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Spectral Med  vs.  Aptose Biosciences

Spectral Med

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Spectral Med are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Spectral Med displayed solid returns over the last few months and may actually be approaching a breakup point.

Aptose Biosciences

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aptose Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Aptose Biosciences displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spectral Med and Aptose Biosciences

The main advantage of trading using opposite Spectral Med and Aptose Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spectral Med position performs unexpectedly, Aptose Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will offset losses from the drop in Aptose Biosciences' long position.

The idea behind Spectral Med and Aptose Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.